HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Opinion: $2 million gene therapy cures require a financing model

"We do not lack cures. We lack the infrastructure to pay for and deliver them," writes William Padula.

By STAT News · Jun 8, 2026 · via STAT News
Opinion: $2 million gene therapy cures require a financing model

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News

Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
The WeekFiercePharma ↗
The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiativ…
Jun 8, 2026
Roche bets $700M upfront on Nurix's late-phase BTK degrader to tee up Lilly showdown
The WeekFierceBiotech ↗
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK …
Jun 8, 2026
Medicare Advantage Expansion Slows but Deepens in 2026
The WeekBriefing
Over half of eligible Medicare beneficiaries are now in Medicare Advantage, with growth concentrated in specia…
Jun 8, 2026